The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project coordinated by the European Brain Council (EBC). According to the World Health Organization, disorders of the brain affect up to one in three people worldwide. 

A second round (VOT2) on new therapeutic areas was launched in 2019, focusing on The Value of Early Diagnosis and Coordinated Care for Rare Diseases (Ataxia, Dystonia and Phenylketonuria); and The Value of Early Intervention and Continuity of Care for Mental Disorders (Anorexia Nervosa, Autism Spectrum Disorder and Major Depressive Disorder).

Prof. Paola Giunti will present a case study on ataxia at the 14th European Paediatric Neurology Society Congress in Glasgow, on 30 April (10:20 – 10:40).

The post Value of Treatment (VOT) case study on ataxia | EPNS Congress 2022 appeared first on European Brain Council (EBC).